SAN FRANCISCO, June 24, 2025 – Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic collaboration with ...
Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem ...
Xcell Biosciences announced today that it has expanded its development and commercial efforts around new market opportunities in immunotherapy drug research and development. The ever-growing ...
LAUSANNE, Switzerland and BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- NewBiologix, a technology innovation company enabling efficient, cost-effective, and scalable production of viral vectors for cell ...
SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences announced today the company has closed a $12 million Series A private equity financing round. The financing was led by HBM Genomics along with the ...
LAUSANNE, Switzerland--(BUSINESS WIRE)--NewBiologix, a technology innovation company pioneering innovative tools enabling efficient, cost-effective, and large-scale production of viral vectors for ...
In recent years, fed-batch biomanufacturing has begun giving way to continuous manufacturing processes, as developers face pressure to balance affordability with high manufacturing quality. Although ...
SAN FRANCISCO, CALIFORNIA, UNITED STATES, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, and Culture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results